Currently Viewing:
In Focus Blog
Currently Reading
Medicare Advantage VBID Model to Cover More States, Add Dementia and Rheumatoid Arthritis
August 11, 2016 – Mary Caffrey
Medicaid Expansion Improving Health, Regardless of Format, Study Finds
August 09, 2016 – Mary Caffrey
GAO Report: Medicaid "Innovation" Waivers Should Expand, Not Restrict Health Coverage
August 08, 2016 – Mary Caffrey
Solera Seeks to Be "Back Office" for Community-Based Diabetes Prevention
August 02, 2016 – Mary Caffrey
Getting Ready for Bundled Payments in Cardiac Care
August 01, 2016 – Mary Caffrey
Looking for a Breakthrough in Alzheimer's as Boomers Age
July 26, 2016 – Mary Caffrey
American Hospital Association Raises Questions About CMS' Release of Star Ratings
July 25, 2016 – Mary Caffrey
Dexcom "Committed" to Bringing CGM to Medicare Population
July 22, 2016 – Mary Caffrey
Value-Based Reimbursement on Track to Eclipse Fee-for-Service by 2020, McKesson Report Finds
July 21, 2016 – Mary Caffrey

Medicare Advantage VBID Model to Cover More States, Add Dementia and Rheumatoid Arthritis

Mary Caffrey
Adding more states and conditions to the Medicare Advantage value-based insurance design model will allow CMS to reach a more diverse group of plans and patients, in both rural and urban settings.
More states and 2 new conditions will be added to a value-based insurance design (VBID) model for Medicare Advantage, CMS announced Wednesday.

Alabama, Texas, and Michigan will join the states currently testing the model in a host of chronic conditions, including diabetes, hypertension, and recovery from stroke. Mood disorders were also included. Two new conditions--rheumatoid arthritis and dementia--will be added starting in January 2018.

The change gives CMS another tool to meet its goal of making 50% of Medicare payments through alternate payment models by 2018. The goal of 30% for 2016 was passed earlier this year.

The first round of the Medicare Advantage VBID model starts in January 2017 and will affect 7 states: Arizona, Iowa, Pennsylvania, Indiana, Oregon, Massachusetts, and Tennessee. MA plans have already applied for that round, and CMS will announce the plans approved for participation next month, according to a statement. Plans approved for that round will operate the model for 5 years.

Opening the model to new conditions and 3 more states, as well as changing the minimum enrollment size, will allow a more diverse group of plans to participate, according to CMS. Federal health officials seek to test the MA-VBID models in a variety of settings, both rural and urban.

Value-based insurance designs seek to encourage high-value clinical services and behavior by making it easier for beneficiaries to gain access to those services that offer the best health outcomes for the best price. Current Medicare Advantage plans have “uniformity” requirements that don’t allow plans to offer differ cost-sharing options to different enrollees. The VBID models being studied allow plans offer “clinically nuanced” cost-sharing tailored to meet patients specific health conditions, with the goal of providing higher quality, more cost-effective care.

According to CMS, the VBID models will be specifically designed to incorporate prescription drug benefits under Medicare Part D.

The announcement states that the VBID models can use 4 different approaches: (1) reduce cost-sharing for high-value services, (2) reduce cost-sharing when using high-value providers, (3) reduce cost-sharing for enrollees who take part in disease management programs, and (4) coverage of additional supplemental benefits.

In diabetes care, for example, VBID models can be used to encourage enrollees with the disease to see a case manager or to use digital technologies.

To participate, MA plans must have quality ratings of 3 stars or higher.


Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome the the new and improved, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up